This result was prevented by co-administration of your CB1 receptor antagonist SR141716a, but not by co-administration with the CB2 receptor antagonist SR144528, suggesting this motion of WIN55,212-2 is mediated by using (2014) Effects of cannabinoid medications to the deficit of prepulse inhibition of startle within an animal model of schizophrenia: https://win55.clinic/xo-so